Mouse IL-4 T cell ELISPOT kit - 5-plate

SKU
CT319-B5
Complete ELISPOT kit including all reagents (480 determinations).
Format
5-plate
Price
€ 670
Documentation
Data sheet
Manual
SDS
Reactivity
Mouse
Category
T cell ELISPOT
Analyte
IL-4
Description
Our ELISPOT kits provide a complete, ready-to-use solution for reliable, high-performance ELISPOT assay. Each kit includes all essential components: coating and detection antibodies, streptavidin-HRP, TMB substrate, blocking stock solution, dilution buffer, and Tween-20.
Description
Interleukin-4 (IL-4) is a key cytokine that plays a central role in regulating the immune system. It is primarily produced by T helper 2 (Th2) cells, but can also be secreted by mast cells, and eosinophils and basophils. IL-4 is involved in several critical immune processes, including IgE class switching in B cell, Th2 cell differentiation, allergic inflammation and defense against parasites.
Alternative names
IL-4, Interleukin 4, Interleukin-4, IL4, BCGF-1, BGF1, BSF-1, BSF1, IL4E12
Gene ID
16189
Related Products
CT319-B2 - Mouse IL-4 T cell ELISPOT kit - 2-plate

References

Authors, et al. Title Journal Year Volume Pages
Wanbo Zhao Administration with Vaccinia Virus Encoding Canine Parvovirus 2 vp2 Elicits Systemic Immune Responses in Mice and Dogs Viral Immunol 2020 33 434-443
Laleh Naghibi Preparation of nanoliposomes containing HER2/neu (P5+435) peptide and evaluation of their immune responses and anti-tumoral effects as a prophylactic vaccine against breast cancer PLoS One 2020 15 e0243550
Lilan Xie Intranasal immunization with recombinant Vaccinia virus Tiantan harboring Zaire Ebola virus gp elicited systemic and mucosal neutralizing antibody in mice Vaccine 2019 37 3335-3342
Atefeh Arab A nano-liposome vaccine carrying E75, a HER-2/neu-derived peptide, exhibits significant antitumour activity in mice J Drug Target 2018 26 365-372
Ghazal Talesh Poly (I:C)-DOTAP cationic nanoliposome containing multi-epitope HER2-derived peptide promotes vaccine-elicited anti-tumor immunity in a murine model Immunol Lett 2016 176 57-64
Fatemeh Fakhraee Coadminstration of L. major amastigote class I nuclease (rLmaCIN) with LPD nanoparticles delays the progression of skin lesion and the L. major dissemination to the spleen in BALB/c mice-based experimental setting Acta Trop 2016 159 211-8
Lei Cao Protective effect of enterovirus‑71 (EV71) virus‑like particle vaccine against lethal EV71 infection in a neonatal mouse model Mol Med Rep 2015 12 2473-80
Sheida Shariat Preparation and characterization of different liposomal formulations containing P5 HER2/neu-derived peptide and evaluation of their immunological responses and antitumor effects Iran J Basic Med Sci 2015 18 506-13
Sheida Shariat P5 HER2/neu-derived peptide conjugated to liposomes containing MPL adjuvant as an effective prophylactic vaccine formulation for breast cancer Cancer Lett 2014 355 54-60
Mercedeh Mansourian Effective induction of anti-tumor immunity using p5 HER-2/neu derived peptide encapsulated in fusogenic DOTAP cationic liposomes co-administrated with CpG-ODN Immunol Lett 2014 162 87-93